TY - JOUR
T1 - Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1
AU - Balsara, Binaifer R.
AU - Pei, Jianming
AU - De Rienzo, Assunta
AU - Simon, Daniela
AU - Tosolini, Alessandra
AU - Lu, You Yong
AU - Shen, Fu Min
AU - Fan, Xianglin
AU - Lin, Wen Yao
AU - Buetow, Kenneth H.
AU - Thomas London, W.
AU - Testa, Joseph R.
N1 - Copyright 2000 Wiley-Liss, Inc.
PY - 2001
Y1 - 2001
N2 - Comparative genomic hybridization (CGH) analysis was used to identify chromosomal imbalances in 52 human primary hepatocellular carcinomas (HCCs). The most prominent changes were gains of part or all of chromosome arms 8q (83% of cases) and Iq (73%) and loss of 16q (63%). Other commonly overrepresented sites were 5p, 7q, and Xq. Recurrent sites of DNA sequence amplification included 8q23-24 (five cases) and 11q13-14 (four cases). Other frequently underrepresented sites were 4q, 8p, 16p, and 17p. Taken collectively, these findings and data from other CGH studies of HCCs define a subset of chromosome segments that are consistently over- or underrepresented and highlight sites of putative oncogenes and tumor suppressor genes, respectively, involved in hepatocellular oncogenesis. Loss of heterozygosity analysis with a panel of polymorphic microsatellite markers distributed along 16q defined a minimal region of chromosomal loss at 16q23.1-24.1, suggesting that this region harbors a tumor suppressor gene whose loss/inactivation may contribute to the pathogenesis of many HCCs.
AB - Comparative genomic hybridization (CGH) analysis was used to identify chromosomal imbalances in 52 human primary hepatocellular carcinomas (HCCs). The most prominent changes were gains of part or all of chromosome arms 8q (83% of cases) and Iq (73%) and loss of 16q (63%). Other commonly overrepresented sites were 5p, 7q, and Xq. Recurrent sites of DNA sequence amplification included 8q23-24 (five cases) and 11q13-14 (four cases). Other frequently underrepresented sites were 4q, 8p, 16p, and 17p. Taken collectively, these findings and data from other CGH studies of HCCs define a subset of chromosome segments that are consistently over- or underrepresented and highlight sites of putative oncogenes and tumor suppressor genes, respectively, involved in hepatocellular oncogenesis. Loss of heterozygosity analysis with a panel of polymorphic microsatellite markers distributed along 16q defined a minimal region of chromosomal loss at 16q23.1-24.1, suggesting that this region harbors a tumor suppressor gene whose loss/inactivation may contribute to the pathogenesis of many HCCs.
KW - Allelic Imbalance/genetics
KW - Carcinoma, Hepatocellular/genetics
KW - Chromosomes, Human, Pair 16/genetics
KW - Female
KW - Gene Dosage
KW - Humans
KW - Liver Neoplasms/genetics
KW - Loss of Heterozygosity/genetics
KW - Male
KW - Nucleic Acid Hybridization
UR - http://www.scopus.com/inward/record.url?scp=0035150349&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000166849300004&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M
DO - 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M
M3 - Article
C2 - 11170281
SN - 1045-2257
VL - 30
SP - 245
EP - 253
JO - Genes Chromosomes and Cancer
JF - Genes Chromosomes and Cancer
IS - 3
ER -